The vaping cessation pill, varenicline, has emerged as a groundbreaking solution for those looking to quit vaping, especially among teens and young adults.With recent clinical trials showing that participants in the varenicline group had more than three times the success rate in quitting compared to those on a placebo, this FDA-approved treatment is garnering attention across the healthcare community.